HLA-C and neoplasm: Engineered bivalent antibody of R023-scDbs comprising a Fab clone that recognizes the Soto-p/MHC complex on the tumor cells and a Fab that engages the T-cell receptor (TCR) CD3 complex expressed on T cells then elicit tumor cells killing by engaged T-cells.